Literature DB >> 3409845

EEG and other early predictors of epilepsy remission: a community study.

S Q Shafer1, W A Hauser, J F Annegers, D W Klass.   

Abstract

The course of seizures was reviewed in all 306 residents of Rochester, Minnesota who had epilepsy diagnosed between 1935 and 1978, lived in the region greater than or equal to 5 years after diagnosis, and had an electroencephalogram (EEG). The life-table probability of having achieved 5 years seizure-free (FYSF) by 20 years after diagnosis was 75%. In a multivariable proportional hazards model, these three variables predicted a significantly higher rate of achieving FYSF: no early-life brain damage (remission rate ratio = 2.27, p less than 0.01), no generalized epileptiform activity (rate ratio = 1.58, p less than 0.05), and never having had a generalized tonic-clonic seizure (rate ratio = 1.4, p less than 0.05). The same three variables, plus age at diagnosis, were descriptors of the rate of reaching FYSF off medication. Gender, family history, type of seizure, and EEG findings other than generalized epileptiform activity were not significantly related to either end point. The predictor set did 15% better than prior probabilities in forecasting FYSF. Although informative about group experience, these predictors are weak clinical discriminators, singly or in a set. FYSF occurred in high proportion of even those persons whose history, clinical examination, or EEG findings placed them in a less favorable stratum of one or more predictors.

Entities:  

Mesh:

Year:  1988        PMID: 3409845     DOI: 10.1111/j.1528-1157.1988.tb03767.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

Review 1.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

Review 2.  Gender-specific differences in the central nervous system's response to anesthesia.

Authors:  Lana J Mawhinney; Davita Mabourakh; Michael C Lewis
Journal:  Transl Stroke Res       Date:  2012-11-29       Impact factor: 6.829

Review 3.  Prognosis of intractable epilepsy: is long-term seizure freedom possible with medical management?

Authors:  Heidi Munger Clary; Hyunmi Choi
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 4.  Do anticonvulsants alter the natural course of epilepsy? Case for early treatment is not established.

Authors:  D Chadwick
Journal:  BMJ       Date:  1995-01-21

Review 5.  The risks and benefits of withdrawing antiepileptic therapy.

Authors:  B Scherokman; B Jabbari
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

Review 6.  Epilepsy.

Authors:  D Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

7.  Remission and relapse in a drug-resistant epilepsy population followed prospectively.

Authors:  Brian Callaghan; Malka Schlesinger; William Rodemer; John Pollard; Dale Hesdorffer; W Allen Hauser; Jacqueline French
Journal:  Epilepsia       Date:  2011-01-26       Impact factor: 5.864

Review 8.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy.

Authors:  Samuel Wiebe; Nathalie Jette
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

Review 9.  The natural history of epilepsy: an epidemiological view.

Authors:  P Kwan; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

Review 10.  Presurgical evaluation and surgical treatment of medically refractory epilepsy.

Authors:  Adrian M Siegel
Journal:  Neurosurg Rev       Date:  2003-10-28       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.